CSPC Pharmaceutical Group saw the highest growth of 156% in patent filings and 124% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 156% and grants by 124%. GlobalData’s DataBook provides a comprehensive analysis of CSPC Pharmaceutical Group’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

CSPC Pharmaceutical Group has been focused on protecting inventions in China(CN) with 16 publications in Q1 2024

The China(CN) Patent Office dominates the patent filings and grants with nearly 22% filings and 67% grants. The China(CN), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where CSPC Pharmaceutical Group is filings its patents. Among the top granted patent authorities, CSPC Pharmaceutical Group has 67% of its grants in China(CN), 20% in Australia(AU) and 7% in United States(US).

F. Hoffmann-La Roche and Bristol-Myers Squibb could be the strongest competitors for CSPC Pharmaceutical Group

Patents related to nanomedicine and rare diseases lead CSPC Pharmaceutical Group's portfolio

CSPC Pharmaceutical Group has the highest number of patents in nanomedicine followed by, rare diseases and immuno-oncology. For nanomedicine, nearly 46% of patents were filed and no patents were granted in Q1 2024.

Mobiles, hand-helds, pdas, smartphones related patents lead CSPC Pharmaceutical Group portfolio followed by breast cancer, and hypopituitarism

CSPC Pharmaceutical Group has highest number of patents in mobiles, hand-helds, pdas, smartphones followed by breast cancer, hypopituitarism, acute respiratory distress syndrome, and acute lung injury. For mobiles, hand-helds, pdas, smartphones, nearly 7% of patents were filed and 8% of patents were granted in Q1 2024.

For comprehensive analysis of CSPC Pharmaceutical Group's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.